Loading company…
Pharaoh Neuro develops technologies for neurocritical care, including cerebrospinal fluid management.
Pharaoh Neuro develops the Neurapheresis™ platform for managing cerebrospinal fluid in neurocritical care patients. Its products are intended for hospitals and specialists treating serious neurological conditions. Based in Minneapolis, US, the company raised USD 20.00 mn in Series A funding led by Arboretum Ventures, with Hatteras Venture Partners, IAG Capital Partners, and Laerdal Million Lives Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in